TheProfitWatch

PLRX - Pliant Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.51 0.04 (2.98%) --- 0.0 (0.0%) -0.01 (-0.64%) 0.0 (0.0%) 0.03 (2.07%) 0.01 (0.65%) -0.04 (-2.58%)

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.71
Diluted EPS:
-0.71
Basic P/E:
-2.1901
Diluted P/E:
-2.1901
RSI(14) 1m:
33.33
VWAP:
1.56
RVol:

Events

Period Kind Movement Occurred At

Related News